DE3683201D1 - Anwendung von ubidecarenon coenzym q10 zur behandlung von dekubitus. - Google Patents

Anwendung von ubidecarenon coenzym q10 zur behandlung von dekubitus.

Info

Publication number
DE3683201D1
DE3683201D1 DE8686103423T DE3683201T DE3683201D1 DE 3683201 D1 DE3683201 D1 DE 3683201D1 DE 8686103423 T DE8686103423 T DE 8686103423T DE 3683201 T DE3683201 T DE 3683201T DE 3683201 D1 DE3683201 D1 DE 3683201D1
Authority
DE
Germany
Prior art keywords
ubidecarenon
decubitus
coenzyme
treatment
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686103423T
Other languages
English (en)
Inventor
Shinichi Okuyama
Kazumaro Furuse
Shigemitsu Ohsawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3683201D1 publication Critical patent/DE3683201D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE8686103423T 1985-03-15 1986-03-14 Anwendung von ubidecarenon coenzym q10 zur behandlung von dekubitus. Expired - Fee Related DE3683201D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60050543A JPS61210028A (ja) 1985-03-15 1985-03-15 褥瘡治療剤

Publications (1)

Publication Number Publication Date
DE3683201D1 true DE3683201D1 (de) 1992-02-13

Family

ID=12861926

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686103423T Expired - Fee Related DE3683201D1 (de) 1985-03-15 1986-03-14 Anwendung von ubidecarenon coenzym q10 zur behandlung von dekubitus.

Country Status (4)

Country Link
US (1) US4767624A (de)
EP (1) EP0208833B1 (de)
JP (1) JPS61210028A (de)
DE (1) DE3683201D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003015A1 (en) * 1986-10-23 1988-05-05 Arval S.P.A. Cosmetic preparations containing ubidecarenones
US20040034107A1 (en) * 1999-02-11 2004-02-19 Mse Pharmazeutika Gmbh Ubiquinone Qn for the treatment of pain
DE19944137A1 (de) * 1999-09-15 2001-03-22 Beiersdorf Ag O/W-Emulsionen mit einem Gehalt an einem oder mehreren Biochinonen und einem erhöhten Gehalt an Glycerin
JP3549197B2 (ja) * 2001-08-10 2004-08-04 日清ファルマ株式会社 ユビキノン含有製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031265A (en) * 1975-06-18 1977-06-21 The United States Of America As Represented By The Secretary Of Agriculture Method of reducing bitterness in citrus juices
JPS5942649B2 (ja) * 1976-02-14 1984-10-16 エーザイ株式会社 重症筋無力症治療剤
JPS5938202B2 (ja) * 1976-03-05 1984-09-14 エーザイ株式会社 難聴治療剤
FR2472384A1 (fr) * 1979-12-27 1981-07-03 Sederma Sa Utilisation en cosmetologie de complexes naturels constitues d'ubiquinones et de phospholipides
JPS56150014A (en) * 1980-04-21 1981-11-20 Takeda Chem Ind Ltd Antiallergic agent
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
CH649917A5 (en) * 1982-03-19 1985-06-28 Italfarmaco Sa Pharmaceutical formulations containing the coenzyme Q(10) suitable for topical administration
JPS60100517A (ja) * 1983-11-08 1985-06-04 Eisai Co Ltd 放射線潰瘍治療剤および方法

Also Published As

Publication number Publication date
JPS61210028A (ja) 1986-09-18
EP0208833A3 (en) 1989-06-07
EP0208833A2 (de) 1987-01-21
EP0208833B1 (de) 1992-01-02
US4767624A (en) 1988-08-30

Similar Documents

Publication Publication Date Title
FI874671A (fi) Anordning foer foerhindrande av laeckage i tryckledningar.
DE3688296D1 (de) Arzneimittel zur behandlung von erbrechen.
DE3683318D1 (de) Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege.
NO874810L (no) Hydroformylering ved bruk av fosfin-ligander med lav flyktighet.
NO894929D0 (no) Verktoey for behandling av undergrunnsbroenner.
DE3670398D1 (de) Quelle fluessiger metallionen.
DE3667605D1 (de) Windel zur verhuetung von wundliegen.
DE3670310D1 (de) Elektrochemische behandlung von ligninen.
DE3782028T2 (de) Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen.
DE3670956D1 (de) Behandlung von fluessigkeiten.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
DE3680881D1 (de) Behandlung von hologrammen.
DE3683201D1 (de) Anwendung von ubidecarenon coenzym q10 zur behandlung von dekubitus.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE3485580D1 (de) Algorithmus zur verabreichung von insulin.
NO881255D0 (no) Behandling av fluider.
ES551763A0 (es) Procedimiento para la depuracion de aguas residuales
DE68907569T2 (de) Mittel zur Behandlung oder Vorbeugung von Aids.
DE3686688T2 (de) Verwendung von sulfanilamido quinoxalinen zur behandlung von neoplastischen krankheiten.
NO158797C (no) Fremgangsmaate for behandling av halidholdige avloepsvaesker.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
DE3675866D1 (de) Methode zur herstellung von diphenylmethandicarbamidsaeureestern.
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
DK160821C (da) 1,3-dihydro-4-benzoyl-2h-imidazol-2-oner samt middel til behandling af hjertesvigt
DE3577985D1 (de) Organotitan-verbindungen und oberflaechenbehandlungsmittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee